First Set of 1-Year Clinical Results from RESOLVE Trial in Eosinophilic Esophagitis , Durable and Sustained Symptom & Tissue Responses after Dosing with EP-104GI Biotech Investing
Cizzle Brands Announces CWENCH Hydration is Now the Official Sport Drink of the NHL's Ottawa Senators Biotech Investing
Theratechnologies Announces Independent Proxy Advisor Firms ISS and Glass Lewis Recommend Shareholders Vote "FOR" the Proposed Plan of Arrangement with Future Pak Biotech Investing
Anavex Life Sciences to Present at the H.C. Wainwright 27th Annual Global Investment Conference 2025 Biotech Investing
Atea Pharmaceuticals to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference Biotech Investing
Adicet Bio to Present at the H.C. Wainwright 27th Annual Global Investment Conference Biotech Investing
Tenaya Therapeutics Presents Interim Data from MyClimb Natural History Study of MYBPC3-associated HCM Pediatric Patients at European Society of Cardiology Congress 2025 Biotech Investing
Exelixis Announces Appointment of Dana T. Aftab, Ph.D. as Executive Vice President, Research and Development Biotech Investing
